Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
2
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
2
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2020-11-10 10:08 | Report Abuse
5 October 2020: HS Bio Supplies Sdn Bhd (Hong Seng’s 51% subsidiary) entered into agreement with RP Integrated Bhd to pursue distributorship of vaccines from Shanghai Fosun Pharmaceutical Group Co. Ltd. (Bursa Announcement)
4 November 2020: Shanghai Fosun Pharmaceutical Group Co. Ltd. to seek approval for BioNTech’s Covid-19 second vaccine known as BNT162b2. (Reuters)
9 November 2020: Pfizer and BioNTech’s BNT162b2 vaccine is 90% effective.
Stock: [HONGSENG]: HONG SENG CONSOLIDATED BERHAD
2020-11-14 15:23 | Report Abuse
13 November 2020: China approves Shanghai Fosun Pharmaceutical Group Co. Ltd to run human testing for BioNTech's COVID-19 vaccine BNT162b2. (Reuters)